RAD51D and neoplasm: On the basis of the recommendations by the expert panel, which is a tumor board that provides molecular and clinical interpretations and suggestions for the results of oncology panel testing, the patient received genetic counseling and subsequently underwent germline analysis for RAD51D c.904-2A > T [NM_002878].